Jan 06, 2017 13:18 pm UTC| Business
ST. THOMAS, U.S. Virgin Islands; LAUSANNE, Switzerland; FT. LAUDERDALE, Fla.; and HAMILTON, Bermuda, Jan. 06, 2017 -- Auven Therapeutics, an international private equity company focused on the accelerated development of...
Jan 06, 2017 13:01 pm UTC| Business
TORONTO, Jan. 06, 2017 -- Intellipharmaceutics International Inc.(Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...
Jan 06, 2017 13:01 pm UTC| Business
TORONTO, Jan. 06, 2017 -- Intellipharmaceutics International Inc.(Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...
magicJack to Review Carnegie’s Director Nominees
Jan 06, 2017 13:01 pm UTC| Business
WEST PALM BEACH, Fla. and NETANYA, Israel, Jan. 06, 2017 -- magicJack VocalTec Ltd. (Nasdaq:CALL) (the “Company”), a leading VoIP cloud-based communications and UCaaS company, today acknowledged receipt of and issued...
magicJack to Review Carnegie’s Director Nominees
Jan 06, 2017 13:01 pm UTC| Business
WEST PALM BEACH, Fla. and NETANYA, Israel, Jan. 06, 2017 -- magicJack VocalTec Ltd. (Nasdaq:CALL) (the “Company”), a leading VoIP cloud-based communications and UCaaS company, today acknowledged receipt of and issued...
Jan 06, 2017 13:01 pm UTC| Business
The abstract, to be presented at the upcoming 2017 Cholangiocarcinoma Foundation Annual Conference, describes positive findings from non-clinical studies and the Phase I clinical study with YELIVA® (ABC294640), suggesting...
Jan 06, 2017 13:01 pm UTC| Business
The abstract, to be presented at the upcoming 2017 Cholangiocarcinoma Foundation Annual Conference, describes positive findings from non-clinical studies and the Phase I clinical study with YELIVA® (ABC294640), suggesting...